Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-1,004,300
Closed -$30.4M 10558
2025
Q4
$30.4M Buy
1,004,300
+623,100
+163% +$15.3M ﹤0.01% 2165
2025
Q3
$7.55M Buy
381,200
+310,000
+435% +$6.48M ﹤0.01% 3600
2025
Q2
$1.78M Sell
71,200
-678,800
-91% -$15.3M ﹤0.01% 4941
2025
Q1
$17.6M Buy
+750,000
New +$21.7M ﹤0.01% 2470
2024
Q3
Sell
-32,000
Closed -$945K 9544
2024
Q2
$945K Sell
32,000
-137,100
-81% -$3.94M ﹤0.01% 4470
2024
Q1
$5.16M Sell
169,100
-132,100
-44% -$3.73M ﹤0.01% 2941
2023
Q4
$7.05M Buy
+301,200
New +$7.28M ﹤0.01% 2408
2023
Q3
Sell
-300
Closed -$10.6K 9512
2023
Q2
$10.6K Sell
300
-31,000
-99% -$867K ﹤0.01% 7130
2023
Q1
$753K Sell
31,300
-26,024
-45% -$603K ﹤0.01% 4353
2022
Q4
$1.27M Buy
57,324
+22,524
+65% +$522K ﹤0.01% 3844
2022
Q3
$827K Hold
34,800
﹤0.01% 3912
2022
Q2
$809K Sell
34,800
-37,500
-52% -$1.01M ﹤0.01% 3898
2022
Q1
$2.96M Buy
+72,300
New +$3.77M ﹤0.01% 3065

Other funds holding CFLT

UBS Group's CFLT Position: Q1 2026 in Review

UBS Group sold out of Confluent (CFLT) in Q1 2026, closing a stake of 12,864,520 shares — an estimated $389M sold.

UBS Group first reported a position in CFLT in Q3 2021 and held it in 18 quarters. The position peaked at $389M in Q4 2025. 4 funds tracked by Wall St. Rank hold CFLT as of Q1 2026.

  • UBS Group reported no remaining Confluent position as of Q1 2026 after selling out during the quarter.
  • UBS Group sold 12,864,520 Confluent shares in Q1 2026, an estimated $389M.
  • UBS Group first reported a position in Confluent in Q3 2021 and held it in 18 quarters.
  • UBS Group's Confluent position peaked at $389M in Q4 2025.
  • 4 funds tracked by Wall St. Rank held Confluent as of Q1 2026.

Based on UBS Group's 13F filing for Q1 2026, filed 5 May 2026.